Lundbeck
HLUN-B.CO
#2637
Rank
โ‚น585.66 B
Marketcap
โ‚น617.09
Share price
-0.18%
Change (1 day)
27.44%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): โ‚น73.95 Billion

According to Lundbeck's latest financial reports the company's current earnings are โ‚น3.61 Billion. In 2024 the company made an earning of โ‚น50.13 Billion, an increase over its 2023 earnings that were of โ‚น39.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น73.95 B47.49%
2024 โ‚น50.13 B25.74%
2023 โ‚น39.87 B21.77%
2022 โ‚น32.74 B31.57%
2021 โ‚น24.88 B-4.61%
2020 โ‚น26.09 B-45.06%
2019 โ‚น47.49 B-34.04%
2018 โ‚น72.01 B12.83%
2017 โ‚น63.82 B93.99%
2016 โ‚น32.89 B-137.28%
2015 -โ‚น88.25 Billion-1246.24%
2014 โ‚น7.69 B-72.36%
2013 โ‚น27.85 B4.38%
2012 โ‚น26.68 B-55.18%
2011 โ‚น59.53 B5.65%
2010 โ‚น56.35 B-5.9%
2009 โ‚น59.88 B